Merck & Co., Inc. news

   Watch this stock
Showing stories 21 - 30 of about 170   

Articles published

MRK 55.34 +0.39 (0.71%)
price chart
Merck & Co., Inc. (MRK) Disclose Form-4 Insider Selling of Clark Golestani ...
Merck & Co., Inc. (MRK): Clark Golestani , EVP & Chief Info Officer of Merck & Co., Inc. sold 31,831 shares on Jul 31, 2015.
Merck & Co. Given "AA" Credit Rating by Morningstar (MRK)  Dakota Financial News
Merck & Co., Inc. (MRK) Files Form 4 Insider Selling : Clark Golestani Sells ...
Merck & Co., Inc. (MRK): Clark Golestani , EVP & Chief Info Officer of Merck & Co., Inc. sold 31,831 shares on Jul 31, 2015.
Merck & Company, Inc. (NYSE:MRK) Analyst Price Target Update  Money Flow Index
The 4 Stocks That Weighed on the DJIA Tuesday
The DJIA stock posting the largest daily percentage loss ahead of the close Tuesday was Merck & Co. (NYSE: MRK) which traded down 4.65% at ... company had no specific news today. Verizon Communications Inc. (NYSE: VZ) traded down 2.07% at $43.81.
Merck & Co., Inc. (MRK), Monster Beverage Corp (MNST) Jump On Analyst Upgrades
Shares of Merck & Co., Inc. (NYSE:MRK) and Monster Beverage Corp (NASDAQ:MNST) have both moved upward today thanks to bullish ratings updates by major analysts.
Company Shares of Merck & Company, Inc. (NYSE:MRK) Rally 2.09%
Shares of Merck & Company, Inc. (NYSE:MRK) rose by 2.09% in the past week and 0.61% for the last 4 weeks. In the past week, the shares have outperformed the S&P 500 by 1.41% and the outperformance increases to 2.3% for the last 4 weeks.
Momentum Stock Focus: Merck & Company, Inc. (NYSE:MRK)  Enterprise Leader
GlaxoSmithKline plc, Bayer AG, Merck andamp; Co. Among Pharmaceuticals Most ...
Among dollar-reporting pharma companies, Merck & Co., Inc. (NYSE:MRK) has the biggest exposure to emerging markets. The company derived 32% of its 2Q sales from the segment.
Buzz Stocks: NVIDIA Corporation, Merck & Co., Inc., and Medivation Inc
In the options pits, short-term speculators are more put-skewed than usual, per Merck & Co., Inc.'s Schaeffer's put/call open interest ratio (SOIR) of 0.82, which sits higher than 72% of all similar readings taken in the past year.
Zacks Rating on Merck & Company, Inc.
As much as 13 analysts have advised buy on Merck & Company, Inc. (NYSE:MRK) with an average broker rating of 2.08. Research Analysts at Zacks has the shares a rating of 3, which implies that the firms recommendation is Neutral on the company.
Stocks Alert - Merck & Co., Inc. (MRK), KeyCorp (KEY), Apple Inc. (AAPL ...
Merck & Co., Inc. (NYSE:MRK) started its trading session with the price of $53.40 and closed at $54.42 by scoring 6.35%.
Merck & Company, Inc. Analyst Rating Update
Merck & Company, Inc. (NYSE:MRK) has received a hold rating for the short term, according to the latest rank of 3 from research firm, Zacks.